Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe crawled date : 2021 - 10 - 20 save search
LumiraDx receives approval for its COVID-19 Antigen Test for use in India
Published: 2021-10-20 (Crawled : 21:00) - biospace.com/
LMDX | $0.016 -15.0% 130M
|
|
| O: 20.4%
H: 3.25%
C: -6.7%
covid test india approval covid-19
Lixte Biotechnology to Discuss its Collaboration with Leading European Cancer Centers at the Benzinga Global Small Cap Conference on October 28
Published: 2021-10-20 (Crawled : 14:00) - globenewswire.com
LIXT | $3.351 2.9K
|
Health Technology
|
| O: 0.52%
H: 1.56%
C: -5.73%
europe collaboration cancer biotech technology iot conference
Clinical Data from Editas Medicine’s Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10 to be Presented at the European Society of Gene and Cell Therapy Annual Congress
Published: 2021-10-20 (Crawled : 13:15) - globenewswire.com
EDIT | $5.51 -0.72% 490K
|
Health Technology
|
| O: 0.64%
H: 0.71%
C: -2.76%
europe ongoing phase 1 therapy trial
Voyager Therapeutics Presents Positive Preclinical Data Supporting CNS-Directed GBA1 Gene Therapy at Virtual Congress of the European Society of Gene and Cell Therapy
Published: 2021-10-20 (Crawled : 13:00) - globenewswire.com
VYGR | $7.545 -0.07% 98K
|
Health Technology
|
| O: -0.65%
H: 1.54%
C: -6.58%
europe gene therapy positive therapy preclinical pre-clinical
Intellia Therapeutics Presents Preclinical Data Demonstrating Advancements in its Broad Genome Editing Capabilities at the 2021 European Society of Gene & Cell Therapy Annual Congress
Published: 2021-10-20 (Crawled : 12:00) - globenewswire.com
NTLA | $21.41 0.42% 210K
|
Health Technology
|
| O: 1.61%
H: 2.17%
C: -4.21%
europe genome editing therapy preclinical pre-clinical
RedHill Biopharma to Present at the BIO-Europe 2021 Conference
Published: 2021-10-20 (Crawled : 11:00) - prnewswire.com
RDHL | $0.425 1.0% 120K
|
Health Technology
|
| O: 0.0%
H: 10.53%
C: 5.81%
biopharma europe conference presentation
Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Published: 2021-10-20 (Crawled : 10:00) - biospace.com/
RCKT M | $23.42 -0.26% 64K
|
Health Technology
|
| O: 6.15%
H: 1.44%
C: -2.95%
treatment europe positive therapy trial
Gainers vs Losers
| 80% | 20% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
PAPL | $2.07 26.22% 550K
|
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.